Adamas pharmaceuticals reports q2 loss per share of $0.37

Adamas reports second quarter 2020 financial results.q2 loss per share $0.37.q2 revenue $18.8 million versus refinitiv ibes estimate of $15.3 million.q2 earnings per share estimate $-0.61 -- refinitiv ibes data.qtrly total paid prescriptions grew to 8,150, a 32% increase over q2 2019.

ADMS Ratings Summary

ADMS Quant Ranking